» Articles » PMID: 24372862

Upper Limit of Normal Serum Alanine Aminotransferase Levels in Japanese Subjects

Overview
Journal Hepatol Res
Specialty Gastroenterology
Date 2013 Dec 31
PMID 24372862
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Serum alanine aminotransferase (ALT) is important for screening, diagnosis and management of chronic liver diseases. The incidence of non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH), which is considered a hepatic manifestation of lifestyle-related diseases, is increasing worldwide. However, the upper limit of the normal ALT level has not yet been established because of not excluding many lifestyle-related diseases. The aim of this study was to evaluate the upper limit of normal serum ALT levels in Japanese subjects.

Methods: We analyzed the serum ALT levels of 11 404 Japanese subjects negative for hepatitis B surface antigen and hepatitis C virus antibody, and who received health check-ups. Lifestyle factors related to ALT levels were determined by multivariate analysis. Subjects with all factors identified by multivariate analysis within the normal range were defined as "healthy" subjects. The 90th percentile of ALT levels in healthy subjects was defined as the upper limit of normal ALT.

Results: Whereas alcohol intake was not a significant factor, the following were independently associated with ALT concentration by multivariate analysis: sex; age; body mass index; waist circumference; concentrations of total cholesterol, high-density lipoprotein cholesterol, triglycerides and fasting blood glucose; and fatty liver on ultrasonography. Healthy subjects consisted of 1462 (21.2%) men and 2046 (45.4%) women, and the 90th percentiles of the ALT levels in the two groups were 29 and 23 IU/L, respectively.

Conclusion: The upper limits of normal ALT when considering lifestyle factors in Japanese subjects were 29 IU/L in men and 23 IU/L in women.

Citing Articles

The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.

Qiu J, Kuang M, Yang R, Yu C, He S, Sheng G Front Endocrinol (Lausanne). 2023; 14:1239398.

PMID: 37727457 PMC: 10505795. DOI: 10.3389/fendo.2023.1239398.


Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range.

Ndrepepa G, Cassese S, Scalamogna M, Lahu S, Aytekin A, Xhepa E J Clin Med. 2023; 12(9).

PMID: 37176615 PMC: 10178981. DOI: 10.3390/jcm12093174.


The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study.

Fujishima Y, Nishizawa H, Kawachi Y, Nakamura T, Akari S, Ono Y Biomedicines. 2023; 11(3).

PMID: 36979653 PMC: 10045538. DOI: 10.3390/biomedicines11030674.


Updated upper limit of normal for serum alanine aminotransferase value in Vietnamese population.

Huong N, Karimzadeh S, Thanh N, Thuan T, Sabbah G, Ismaeil K BMJ Open Gastroenterol. 2022; 9(1).

PMID: 35613736 PMC: 9134171. DOI: 10.1136/bmjgast-2022-000870.


Serum Level of Alanine- and Aspartate-Aminotransferase Levels in Newborns in India.

Chhavi N, Ojha S, Awasthi A, Shalimar , Goel A J Clin Exp Hepatol. 2022; 12(2):306-311.

PMID: 35535103 PMC: 9077228. DOI: 10.1016/j.jceh.2021.08.024.